Methods: The first thirteen patients with pelvic oligorecurrent PCa who underwent [99mTc]Tc-PSMA-I&S RGS using the SENSEI® drop-in gamma probe at the Martini-Klinik (February–June 2024) were retrospectively analyzed. The gene discussed is FOLH1; the disease is posterior cortical atrophy.